Peripheral neuropathies after BRAF and/or MEK inhibitors treatment: A pharmacovigilance study

被引：0
|
作者：
Picca, A. [1 ]
Birzu, C. [1 ]
Berzero, G. [2 ]
Sanchez-Pena, P. [3 ]
Gaboriau, L. [4 ]
Vidil, F. [5 ]
Lenglet, T. [6 ]
Tafani, C. [7 ]
Ricard, D. [7 ]
Psimaras, D. [1 ]
Bihan, K. [8 ]
机构：
[1] Sorbonne Univ, Hop Univ 8 La Pitie Salpetriere Charles Foix, Inst Cerveau, AP HP,CNRS,Inserm,UMR S 1127,ICM, Paris, France
[2] IRCCS San Raffaele Sci Inst, Neurol Unit, Milan, Italy
[3] CHU Bordeaux, Pole Sante Publ, Serv Pharmacol Med, Bordeaux, France
[4] CHU Lille, Serv Pharmacol Med, Ctr Reg Pharmacovigilance, Lille, France
[5] Agence Natl Securite Medicament & Produits Sante, St Denis, France
[6] GH Pitie Salpetriere, AP HP, Dept Neurophysiol Clin, Paris, France
[7] Hop Instruct Armees Percy, Serv Sante Armees, Dept Neurol, Paris, France
[8] GH Pitie Salpetriere, AP HP, Dept Pharmacol, Ctr Reg Pharmacovigilance, Paris, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2022年 / 36卷
关键词：
neuropathy; polyradiculoneuropathy; BRAF inhibitors; MEK inhibitors; neurotoxicity; melanoma; pharmacovigilance; adverse events;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PS-089
引用
收藏
页码：139 / 140
页数：2
相关论文
共 50 条
  • [21] To Inhibit or Not to Inhibit MEK With BRAF Inhibitors: Is That the Question?
    Sullivan, Ryan J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (29) : 4613 - +
  • [22] Uveitis associated with immune checkpoint inhibitors or BRAF/MEK inhibitors in patients with malignant melanoma
    Sada, Ikuyo
    Harada, Yosuke
    Hiyama, Tomona
    Mizukami, Mina
    Kan, Takanobu
    Kawai, Mikio
    Kiuchi, Yoshiaki
    MELANOMA RESEARCH, 2023, 33 (06) : 539 - 546
  • [23] Upfront BRAF/MEK inhibitors for treatment of high-grade glioma: A case report and review of the literature
    Arbour, Gabrielle
    Ellezam, Benjamin
    Weil, Alexander G.
    Cayrol, Romain
    Vanan, Magimairajan Issai
    Coltin, Hallie
    Larouche, Valerie
    Erker, Craig
    Jabado, Nada
    Perreault, Sebastien
    NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
  • [24] From targeted monotherapy to combined BRAF-MEK inhibitors and integrated genome analysis for melanoma treatment
    Roukos, Dimitrios H.
    Papaloukas, Costas
    Tzaphlidou, Margaret
    FUTURE ONCOLOGY, 2013, 9 (01) : 5 - 8
  • [25] PSEUDOVITELLIFORM MACULOPATHY SECONDARY TO BRAF AND MEK INHIBITORS IN A PATIENT WITH METASTASIC MELANOMA
    Alba-Linero, C.
    Rocha De Lossada, C.
    Delgado-Fernandez, A. S.
    Jodar-Marquez, M.
    Calvo De Mora, M. Rodriguez
    Berciano-Guerrero, M. A.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2019, 33 (05) : 1497 - 1500
  • [26] Cutaneous reactions in children treated with MEK inhibitors, BRAF inhibitors, or combination therapy: A multicenter study
    Boull, Christina L.
    Gardeen, Samantha
    Abdali, Talal
    Li, Edward
    Potts, Jolee
    Rubin, Nathan
    Carlberg, Valerie M.
    Gupta, Deepti
    Hunt, Raegan
    Luu, Minnelly
    Maguiness, Sheilagh M.
    Moertel, Christopher L.
    Song, Hannah
    Vivar, Karina L.
    Coughlin, Carrie
    Huang, Jennifer T.
    Lara-Corrales, Irene
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (06) : 1554 - 1561
  • [27] Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma
    Carlino, Matteo S.
    Todd, Jason R.
    Gowrishankar, Kavitha
    Mijatov, Branka
    Pupo, Gulietta M.
    Fung, Carina
    Snoyman, Stephanie
    Hersey, Peter
    Long, Georgina V.
    Kefford, Richard F.
    Rizos, Helen
    MOLECULAR ONCOLOGY, 2014, 8 (03) : 544 - 554
  • [28] Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective Study
    Salzmann, Martin
    Wald, Alexander
    Stege, Henner
    Loquai, Carmen
    Zimmer, Lisa
    Hayani, Kinan M.
    Heinzerling, Lucie
    Gutzmer, Ralf
    Enk, Alexander H.
    Hassel, Jessica C.
    CANCERS, 2023, 15 (05)
  • [29] The Impact of Drug-Drug Interactions on the Toxicity Profile of Combined Treatment with BRAF and MEK Inhibitors in Patients with BRAF-Mutated Metastatic Melanoma
    Mezi, Silvia
    Botticelli, Andrea
    Scagnoli, Simone
    Pomati, Giulia
    Fiscon, Giulia
    De Galitiis, Federica
    Di Pietro, Francesca Romana
    Verkhovskaia, Sofia
    Amirhassankhani, Sasan
    Pisegna, Simona
    Gentile, Giovanna
    Simmaco, Maurizio
    Gohlke, Bjoern
    Preissner, Robert
    Marchetti, Paolo
    CANCERS, 2023, 15 (18)
  • [30] Integrating BRAF/MEK inhibitors into combination therapy for melanoma
    K S M Smalley
    K T Flaherty
    British Journal of Cancer, 2009, 100 : 431 - 435
12345